Xilio Therapeutics, Inc. Company Information
Xilio Therapeutics, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Xilio Therapeutics, Inc.
- Ticker: XLO
- Exchange: NasdaqGS
- Founded: 2016
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$40.441m
- Shares Outstanding: 43.96m
- Website: https://xiliotx.com
Number of Employees
Location
- Xilio Therapeutics, Inc.
- 828 Winter Street
- Suite 300
- Waltham
- Massachusetts
- 02451
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| XLO | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Oct 2021 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/22 11:03 |
| End of Day Share Price | 2024/11/22 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.